Back to

Dr Andrew Stone

Conjoint Senior Lecturer
Medicine & Health
School of Clinical Medicine
  • Book Chapters | 2009
    2009, 'The dark side of antihormonal action in breast cancer', in Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer: New Molecular Aspects and their Potential as Targets, pp. 63 - 83, http://dx.doi.org/10.1007/978-1-4020-8526-0_4
  • Journal articles | 2020
    2020, 'The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderly', Nature Communications, 11, http://dx.doi.org/10.1038/s41467-019-14079-0
    Journal articles | 2019
    Lacaze P; Pinese M; Kaplan W; Stone A; Brion MJ; Woods RL; McNamara M; McNeil JJ; Dinger ME; Thomas DM, 2019, 'The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort design', European Journal of Human Genetics, 27, pp. 308 - 316, http://dx.doi.org/10.1038/s41431-018-0279-z
    Journal articles | 2019
    2019, 'MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer', British Journal of Cancer, 120, pp. 621 - 632, http://dx.doi.org/10.1038/s41416-019-0395-8
    Journal articles | 2017
    Humphris JL; Patch AM; Nones K; Bailey PJ; Johns AL; McKay S; Chang DK; Miller DK; Pajic M; Kassahn KS; Quinn MC J; Bruxner TJ C; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Stone A; Wilson PJ; Anderson M; Fink JL; Holmes O; Kazakoff S; Leonard C; Newell F; Waddell N; Wood S; Mead RS; Xu Q; Wu J; Pinese M; Cowley MJ; Jones MD; Nagrial AM; Chin VT; Chantrill LA; Mawson A; Chou A; Scarlett CJ; Pinho AV; Rooman I; Giry-Laterriere M; Samra JS; Kench JG; Merrett ND; Toon CW; Epari K; Nguyen NQ; Barbour A; Zeps N; Jamieson NB; McKay CJ; Carter CR; Dickson EJ; Graham JS; Duthie F; Oien K; Hair J; Morton JP; Sansom OJ; Grützmann R; Hruban RH; Maitra A; Iacobuzio-Donahue CA; Schulick RD; Wolfgang CL; Morgan RA; Lawlor RT; Rusev B; Corbo V; Salvia R; Cataldo I; Tortora G; Tempero MA; Hofmann O; Eshleman JR; Pilarsky C; Scarpa A; Musgrove EA; Gill AJ; Pearson JV; Grimmond SM; Waddell N; Biankin AV, 2017, 'Hypermutation In Pancreatic Cancer', Gastroenterology, 152, pp. 68 - 74.e2, http://dx.doi.org/10.1053/j.gastro.2016.09.060
    Journal articles | 2015
    Locke WJ; Zotenko E; Stirzaker C; Robinson MD; Hinshelwood RA; Stone A; Reddel RR; Huschtscha LI; Clark SJ, 2015, 'Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis', Clinical Epigenetics, 7, http://dx.doi.org/10.1186/s13148-015-0086-0
    Journal articles | 2015
    Stirzaker C; Zotenko E; Song JZ; Qu W; Nair SS; Locke WJ; Stone A; Armstong NJ; Robinson MD; Dobrovic A; Avery-Kiejda KA; Peters KM; French JD; Stein S; Korbie DJ; Trau M; Forbes JF; Scott RJ; Brown MA; Francis GD; Clark SJ, 2015, 'Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value', Nature Communications, 6, pp. 5899 - 5899, http://dx.doi.org/10.1038/ncomms6899
    Journal articles | 2015
    Stone A; Zotenko E; Locke WJ; Korbie D; Millar EK A; Pidsley R; Stirzaker C; Graham P; Trau M; Musgrove EA; Nicholson RI; Gee JM W; Clark SJ, 2015, 'DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer', Nature Communications, 6, http://dx.doi.org/10.1038/ncomms8758
    Journal articles | 2014
    Stone A; Musgrove EA, 2014, 'Endocrine therapy: Defining the path of least resistance', Breast Cancer Research, 16, http://dx.doi.org/10.1186/bcr3659
    Journal articles | 2013
    Browne BC; Hochgräfe F; Wu J; Millar EK A; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM W; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ, 2013, 'Global characterization of signalling networks associated with tamoxifen resistance in breast cancer', FEBS Journal, 280, pp. 5237 - 5257, http://dx.doi.org/10.1111/febs.12441
    Journal articles | 2013
    Stone A; Cowley MJ; Valdes-Mora F; McCloy RA; Sergio CM; Gallego-Ortega D; Caldon CE; Ormandy CJ; Biankin AV; Gee JM W; Nicholson RI; Print CG; Clark SJ; Musgrove EA, 2013, 'BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer', Molecular Cancer Therapeutics, 12, pp. 1874 - 1885, http://dx.doi.org/10.1158/1535-7163.MCT-13-0012
    Journal articles | 2013
    Stone A; Valdes-Mora F; Clark SJ, 2013, 'Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancer', Epigenomics, 5, pp. 595 - 598, http://dx.doi.org/10.2217/epi.13.70
    Journal articles | 2012
    Caldon CE; Sergio CM; Kang J; Muthukaruppan A; Boersma MN; Stone A; Barraclough J; Lee CS; Black MA; Miller LD; Gee JM; Nicholson RI; Sutherland RL; Print CG; Musgrove EA, 2012, 'Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells', MOLECULAR CANCER THERAPEUTICS, 11, pp. 1488 - 1499, http://dx.doi.org/10.1158/1535-7163.MCT-11-0963
    Journal articles | 2012
    2012, 'Cyclin E2 overexpression is associated with endocrine resistance but not insensivity to CDK2 inhibition in human breast cancer cells', Molecular Cancer Therapeutics, 11, pp. 1488 - 1499, http://dx.doi.org/10.1158/1535-7163.MCT-11-0963
    Journal articles | 2012
    2012, 'ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer', PLoS Biology, 10, pp. e1001461, http://dx.doi.org/10.1371/journal.pbio.1001461
    Journal articles | 2012
    2012, 'Inhibitors of cell cycle kinases: Recent advances and future prospects as cancer therapeutics', Critical Reviews in Oncogenesis, 17, pp. 175 - 198, http://dx.doi.org/10.1615/CritRevOncog.v17.i2.40
    Journal articles | 2012
    2012, 'Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer', PLoS One, 7, pp. e40466, http://dx.doi.org/10.1371/journal.pone.0040466
    Journal articles | 2011
    2011, 'Cyclin D as a therapeutic target in cancer', Nature Reviews Cancer, 11, pp. 558 - 572, http://dx.doi.org/10.1038/nrc3090
    Journal articles | 2008
    2008, 'Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity', Breast Cancer Research, 10, http://dx.doi.org/10.1186/bcr1925
    Journal articles | 2003
    2003, 'FDA issues felled advanced tissue sciences', Genetic Engineering News, 23
  • Reports | 2022
    2022, Tasmanian Drug Trends 2022: Key Findings from the Illicit Drug Reporting System (IDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/119r-jg49
    Preprints | 2018
    2018, MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ Breast Cancer, , http://dx.doi.org/10.1101/329227
    Conference Papers | 2016
    2016, 'Abstract 1980: Long-range regulation of HOTAIR identifies novel biomarkers of breast cancer outcome and suggests a role in genome instability', in Cancer Research, American Association for Cancer Research (AACR), pp. 1980 - 1980, presented at Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA, http://dx.doi.org/10.1158/1538-7445.am2016-1980